For example, there is one particularly interesting member, ADAM8, whose expression level has been associated with poor clinical prognosis in several cancers, including breast and pancreatic cancer (Schlomann et al., 2015; Conrad et al., 2018). This evidence concerns the gene ADAM8 and cancer.